J Korean Neurol Assoc.
2016 Aug;34(3):184-192. 10.17340/jkna.2016.3.3.
Focused Update of Guidelines for Antithrombotic Management of Patients with Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack
- Affiliations
-
- 1Department of Neurology, Seoul National University Hospital, Seoul, Korea.
- 2Department of Neurology, Hallym Neurological Institute, Anyang, Korea. ykh1030@hallym.ac.kr
- 3Department of Neurology, Yonsei University Hospital, Seoul, Korea.
- 4Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea.
- 5Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.
- 6Department of Neurology, Inha University Hospital, Incheon, Korea.
- 7Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- 8Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
- KMID: 2345240
- DOI: http://doi.org/10.17340/jkna.2016.3.3
Abstract
- Cardioembolic stroke related to atrial fibrillation is problematic due to high recurrence, mortality, and morbidity rates. The optimal anticoagulant therapy therefore needs to be applied to prevent the occurrence of a second stroke in patients with nonvalvular atrial fibrillation. The oral anticoagulant warfarin has traditionally been used, but it is limited by its narrow efficacy window, complex pharmacokinetics, and multiple drug interactions, thus requiring frequent blood monitoring. New oral anticoagulants have recently been developed that target a specific coagulation component. Dabigatran (a direct thrombin inhibitor) and rivaroxaban, apixaban, and edoxaban (inhibitors of factor Xa) have advantages of rapid action time, short half-life, stable plasma concentration, and few drug interactions. Large randomized clinical trials and meta-analyses have recently been published on the efficacy and safety of these new oral anticoagulants. Based on the results obtained in recent clinical trials, we have revised the recommendations for selecting optimal anticoagulant therapy in patients with nonvalvular atrial fibrillation.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
- The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
- Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
- Selective Gray Matter Infarction in the Basal Ganglia Associated With Transient Ischemic Attack
- Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
